Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

For the second year in a row, the US has surpassed 25,000 whooping cough cases — another sign of the risks of falling vaccination levels.

Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

Infections accelerate aging by damaging cells and organs. Preventing them with vaccines, hand hygiene, masks, and clean air ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

The Delhi High Court, in a matter involving claim of Customs Duty exemption on import of Enzyme linked Immuno Absorbent Assay (ELISA) Kits for antibiotic testing in food as 'diagnostic kits' ...

Doctors are seeing an increase in patients with coughs, colds, and more severe respiratory symptoms due to the flu, with the ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

FDA officials want to rewrite the rules governing vaccines, but former leaders warn the changes could have lasting ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

As of Friday, December 26, ImmuCell Corporation’s ICCC share price has surged by 14.28%, which has investors questioning if this is right time to sell.